DarioHealth Corp (NASDAQ: DRIO) has experienced a rise in its stock price by 30.50 compared to its previous closing price of 0.56. However, the company has seen a gain of 29.57% in its stock price over the last five trading days. prnewswire.com reported 2025-04-08 that Second major healthcare employer signs with DarioHealth, accelerating growth in 2025 and reinforcing its leadership in AI-powered, clinically validated digital health solutions for chronic condition management NEW YORK, April 8, 2025 /PRNewswire/ — DarioHealth Corp. (NASDAQ: DRIO) (“Dario” or the “Company”), a leader in the global digital health market, today announced a new employer partnership with one of the nation’s most respected research and medical institutions. The signed agreement is already live and generating recurring revenue in 2025, marking a significant milestone in Dario’s ongoing expansion among innovation-driven employers seeking measurable health outcomes and ROI.
Is It Worth Investing in DarioHealth Corp (NASDAQ: DRIO) Right Now?
The 36-month beta value for DRIO is also noteworthy at 1.57. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for DRIO is 30.92M, and at present, short sellers hold a 8.75% of that float. The average trading volume of DRIO on April 14, 2025 was 674.41K shares.
DRIO’s Market Performance
The stock of DarioHealth Corp (DRIO) has seen a 29.57% increase in the past week, with a 11.91% rise in the past month, and a -21.13% fall in the past quarter. The volatility ratio for the week is 14.75%, and the volatility levels for the past 30 days are at 9.84% for DRIO. The simple moving average for the past 20 days is 13.90% for DRIO’s stock, with a -15.30% simple moving average for the past 200 days.
Analysts’ Opinion of DRIO
Many brokerage firms have already submitted their reports for DRIO stocks, with TD Cowen repeating the rating for DRIO by listing it as a “Hold.” The predicted price for DRIO in the upcoming period, according to TD Cowen is $1 based on the research report published on January 29, 2025 of the current year 2025.
Alliance Global Partners, on the other hand, stated in their research note that they expect to see DRIO reach a price target of $8.75. The rating they have provided for DRIO stocks is “Buy” according to the report published on May 13th, 2022.
Cowen gave a rating of “Outperform” to DRIO, setting the target price at $31 in the report published on April 22nd of the previous year.
DRIO Trading at 11.04% from the 50-Day Moving Average
After a stumble in the market that brought DRIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.40% of loss for the given period.
Volatility was left at 9.84%, however, over the last 30 days, the volatility rate increased by 14.75%, as shares surge +8.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.36% upper at present.
During the last 5 trading sessions, DRIO rose by +29.57%, which changed the moving average for the period of 200-days by -35.79% in comparison to the 20-day moving average, which settled at $0.6371. In addition, DarioHealth Corp saw -7.70% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DRIO starting from Nelson Steven Charles, who purchase 5,000 shares at the price of $0.91 back on Nov 12 ’24. After this action, Nelson Steven Charles now owns 55,000 shares of DarioHealth Corp, valued at $4,546 using the latest closing price.
Nelson Steven Charles, the Chief Commercial Officer of DarioHealth Corp, purchase 5,000 shares at $0.84 during a trade that took place back on Sep 10 ’24, which means that Nelson Steven Charles is holding 45,000 shares at $4,221 based on the most recent closing price.
Stock Fundamentals for DRIO
Current profitability levels for the company are sitting at:
- -5.52 for the present operating margin
- 0.49 for the gross margin
The net margin for DarioHealth Corp stands at -1.19. The total capital return value is set at -1.46. Equity return is now at value -46.09, with -27.87 for asset returns.
Based on DarioHealth Corp (DRIO), the company’s capital structure generated 0.3 points at debt to capital in total, while cash flow to debt ratio is standing at -1.28. The debt to equity ratio resting at 0.42. The interest coverage ratio of the stock is 63.78.
Currently, EBITDA for the company is -57.74 million with net debt to EBITDA at -0.05. When we switch over and look at the enterprise to sales, we see a ratio of 1.21. The receivables turnover for the company is 5.05for trailing twelve months and the total asset turnover is 0.23. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.42.
Conclusion
In summary, DarioHealth Corp (DRIO) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
